Louisa Dal Cengio

456 total citations
6 papers, 260 citations indexed

About

Louisa Dal Cengio is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Louisa Dal Cengio has authored 6 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Louisa Dal Cengio's work include Genetic Neurodegenerative Diseases (6 papers), Mitochondrial Function and Pathology (5 papers) and Muscle Physiology and Disorders (4 papers). Louisa Dal Cengio is often cited by papers focused on Genetic Neurodegenerative Diseases (6 papers), Mitochondrial Function and Pathology (5 papers) and Muscle Physiology and Disorders (4 papers). Louisa Dal Cengio collaborates with scholars based in Canada and United States. Louisa Dal Cengio's co-authors include Michael R. Hayden, Lisa M. Anderson, Amber L. Southwell, Yuanyun Xie, Lynn A. Raymond, Nicholas S. Caron, Seung‐Hyun Ko, Erika B. Villanueva, Matthew P. Parsons and Douglas R. Langbehn and has published in prestigious journals such as Nucleic Acids Research, Human Molecular Genetics and Science Translational Medicine.

In The Last Decade

Louisa Dal Cengio

6 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louisa Dal Cengio Canada 5 207 200 76 17 16 6 260
Ullrich Wuellner Germany 6 212 1.0× 188 0.9× 72 0.9× 15 0.9× 15 0.9× 9 289
Marie‐Lorraine Monin France 9 213 1.0× 211 1.1× 93 1.2× 29 1.7× 6 0.4× 14 293
Zuzana Mušová Czechia 8 221 1.1× 166 0.8× 61 0.8× 35 2.1× 9 0.6× 21 261
Karsten Tillack Germany 4 122 0.6× 132 0.7× 69 0.9× 31 1.8× 10 0.6× 4 222
Alejandro Mas Monteys United States 5 238 1.1× 135 0.7× 44 0.6× 26 1.5× 21 1.3× 6 275
Suran Nethisinghe United Kingdom 9 227 1.1× 220 1.1× 64 0.8× 25 1.5× 9 0.6× 15 295
Nicolas Chrestian Canada 10 195 0.9× 142 0.7× 43 0.6× 26 1.5× 34 2.1× 24 272
Emilia K. Bijlsma Netherlands 10 273 1.3× 295 1.5× 141 1.9× 47 2.8× 22 1.4× 15 395
Aude Tessier France 5 152 0.7× 144 0.7× 58 0.8× 28 1.6× 5 0.3× 11 246
Sriram Jayabal Canada 8 137 0.7× 138 0.7× 50 0.7× 20 1.2× 7 0.4× 9 213

Countries citing papers authored by Louisa Dal Cengio

Since Specialization
Citations

This map shows the geographic impact of Louisa Dal Cengio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louisa Dal Cengio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louisa Dal Cengio more than expected).

Fields of papers citing papers by Louisa Dal Cengio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louisa Dal Cengio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louisa Dal Cengio. The network helps show where Louisa Dal Cengio may publish in the future.

Co-authorship network of co-authors of Louisa Dal Cengio

This figure shows the co-authorship network connecting the top 25 collaborators of Louisa Dal Cengio. A scholar is included among the top collaborators of Louisa Dal Cengio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louisa Dal Cengio. Louisa Dal Cengio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Bartl, Stefan, Yuanyun Xie, Nalini Potluri, et al.. (2023). Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease. Neurobiology of Disease. 190. 106376–106376. 2 indexed citations
2.
Schmidt, Mandi E., Nicholas S. Caron, Amirah E.-E. Aly, et al.. (2020). DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease. Frontiers in Cellular Neuroscience. 14. 590569–590569. 23 indexed citations
3.
Caron, Nicholas S., Amber L. Southwell, Cynthia Brouwers, et al.. (2019). Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease. Nucleic Acids Research. 48(1). 36–54. 58 indexed citations
4.
Southwell, Amber L., Holly Kordasiewicz, Douglas R. Langbehn, et al.. (2018). Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease. Science Translational Medicine. 10(461). 89 indexed citations
5.
Schmidt, Mandi E., et al.. (2018). Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease. BMC Biology. 16(1). 58–58. 12 indexed citations
6.
Southwell, Amber L., Amy Smith-Dijak, Chris Kay, et al.. (2016). An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes. Human Molecular Genetics. 25(17). 3654–3675. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026